Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,400 | 16,803 | 8,589 | 13,741 | 22,385 |
| Receivables | N/A | N/A | N/A | 50 | N/A |
| TOTAL | $12,261 | $17,766 | $9,405 | $14,862 | $23,442 |
| Non-Current Assets | |||||
| PPE Net | 254 | 256 | 297 | 327 | 347 |
| Other Non-Current Assets | 57 | 99 | 141 | 0 | 0 |
| TOTAL | $311 | $355 | $438 | $327 | $347 |
| Total Assets | $12,572 | $18,121 | $9,843 | $15,189 | $23,789 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 74 | 74 | 74 | N/A | 2,489 |
| Accounts payable and accrued liabilities | 265 | 589 | 1,061 | 957 | 1,721 |
| Accrued Expenses | 1,095 | 1,015 | 980 | 1,208 | 1,505 |
| TOTAL | $1,491 | $1,777 | $2,256 | $2,165 | $5,715 |
| Non-Current Liabilities | |||||
| Long Term Debt | 138 | 156 | 175 | 1,134 | 1,134 |
| TOTAL | $138 | $156 | $175 | $1,134 | $1,134 |
| Total Liabilities | $1,629 | $1,933 | $2,431 | $3,299 | $6,849 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 203 | 203 | 203 | 147 | 147 |
| Common Shares | 4 | 4 | 3 | 3 | 3 |
| Retained earnings | -309,839 | -304,456 | -299,861 | -295,230 | -290,024 |
| Other shareholders' equity | -11 | -11 | -11 | -11 | -11 |
| TOTAL | $10,943 | $16,188 | $7,412 | $11,890 | $16,940 |
| Total Liabilities And Equity | $12,572 | $18,121 | $9,843 | $15,189 | $23,789 |